BRIEF-Bausch + Lomb confirms submission of Vesneo(TM) NDA to US FDA
July 24, 2015 at 01:55 AM EDT
* Noted the confirmation by Valeant Pharmaceuticals International Inc's., wholly owned subsidiary, Bausch + Lomb, that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval for Vesneo(TM)